OBJECTIVE: Our purpose is to explain the onset, diagnosis, and treatment of pancreatic tumor-associated pancreatitis (PTP), and inform clinicians about the management of PTP. It is hoped that clinicians can gain some experience and inspiration from this review, so that patients can obtain better treatment results. BACKGROUND: Acute pancreatitis (AP) is an inflammatory disease, and pancreatic tumors are one of the causes of pancreatitis. When pancreatic tumors and pancreatitis exist at the same time, and there is a "connection" between them, this type of pancreatitis is referred to as PTP. The manifestations of PTP can be as follows: (I) AP is the first symptom of pancreatic tumors; (II) pancreatitis is found in patients after pancreatic tumor diagnosis or during pancreatic tumor surgery. Because pancreatic tumors are not one of the most common causes of pancreatitis, PTP has not attracted the attention of researchers and clinicians, and there is no consistent and clear understanding of the diagnosis and treatment of PTP. METHODS: From the online database PubMed (https://pubmed.ncbi.nlm.nih.gov/) and Web of Science (https://webofknowledge.com/), we use specific retrieval strategies to retrieve relevant articles, and we review and discuss them. CONCLUSIONS: What we need to realize is that PTP is different from ordinary AP. It has its own characteristics in terms of diagnosis and treatment, which requires the attention of clinicians. More importantly, future research should design the best diagnosis and treatment algorithms for PTP. 2021 Gland Surgery. All rights reserved.
OBJECTIVE: Our purpose is to explain the onset, diagnosis, and treatment of pancreatic tumor-associated pancreatitis (PTP), and inform clinicians about the management of PTP. It is hoped that clinicians can gain some experience and inspiration from this review, so that patients can obtain better treatment results. BACKGROUND: Acute pancreatitis (AP) is an inflammatory disease, and pancreatic tumors are one of the causes of pancreatitis. When pancreatic tumors and pancreatitis exist at the same time, and there is a "connection" between them, this type of pancreatitis is referred to as PTP. The manifestations of PTP can be as follows: (I) AP is the first symptom of pancreatic tumors; (II) pancreatitis is found in patients after pancreatic tumor diagnosis or during pancreatic tumor surgery. Because pancreatic tumors are not one of the most common causes of pancreatitis, PTP has not attracted the attention of researchers and clinicians, and there is no consistent and clear understanding of the diagnosis and treatment of PTP. METHODS: From the online database PubMed (https://pubmed.ncbi.nlm.nih.gov/) and Web of Science (https://webofknowledge.com/), we use specific retrieval strategies to retrieve relevant articles, and we review and discuss them. CONCLUSIONS: What we need to realize is that PTP is different from ordinary AP. It has its own characteristics in terms of diagnosis and treatment, which requires the attention of clinicians. More importantly, future research should design the best diagnosis and treatment algorithms for PTP. 2021 Gland Surgery. All rights reserved.
Authors: Stephen E Roberts; Sian Morrison-Rees; Ann John; John G Williams; Tim H Brown; David G Samuel Journal: Pancreatology Date: 2017-01-19 Impact factor: 3.996
Authors: Ali A Aghdassi; Daniel S John; Matthias Sendler; F Ulrich Weiss; Thomas Reinheckel; Julia Mayerle; Markus M Lerch Journal: J Biol Chem Date: 2017-12-11 Impact factor: 5.157
Authors: Gyorgy Biczo; Eszter T Vegh; Natalia Shalbueva; Olga A Mareninova; Jason Elperin; Ethan Lotshaw; Sophie Gretler; Aurelia Lugea; Sudarshan R Malla; David Dawson; Piotr Ruchala; Julian Whitelegge; Samuel W French; Li Wen; Sohail Z Husain; Fred S Gorelick; Peter Hegyi; Zoltan Rakonczay; Ilya Gukovsky; Anna S Gukovskaya Journal: Gastroenterology Date: 2017-10-23 Impact factor: 22.682
Authors: Lotte Boxhoorn; Rogier P Voermans; Stefan A Bouwense; Marco J Bruno; Robert C Verdonk; Marja A Boermeester; Hjalmar C van Santvoort; Marc G Besselink Journal: Lancet Date: 2020-09-05 Impact factor: 79.321